Lead sponsor
Mediti Pharma Inc.
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
81
Total enrollment
20
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionMultiple dementia etiologiesPh 2Terminated81